Review article: The hepatic manifestations of hereditary haemorrhagic telangiectasia

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 5, 2008, Pages 523-533

  Sabba C ^a   Pompili, M ^b  

^a UNIVERSITY OF BARI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEVACIZUMAB; DIGOXIN; FUROSEMIDE; NADOLOL; OCTREOTIDE; PROPRANOLOL; SOMATOSTATIN DERIVATIVE; SPIRONOLACTONE; TERLIPRESSIN; VAPREOTIDE;

ARTERIOVENOUS SHUNT; ARTICLE; ARTIFICIAL EMBOLISM; BILIARY TRACT DISEASE; CHOLANGITIS; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EPIDEMIC; ESOPHAGUS VARICES BLEEDING; HEART ARRHYTHMIA; HEART FAILURE; HISTOPATHOLOGY; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER ANGIOGRAPHY; LIVER DISEASE; LIVER ISCHEMIA; LIVER NECROSIS; LIVER TRANSPLANTATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SCREENING TEST; SYMPTOMATOLOGY;

BILIARY TRACT DISEASES; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PORTAL; LIVER DISEASES; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULAR FISTULA;

EID: 48449084739     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03775.x     Document Type: Article

References (73)

1. Rendu HJ. Épistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Gaz Hop 1896 : 1322 3.
2. Osler W. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Bull Johns Hopkins Hosp 1901 12 : 333 7.
3. Weber FP. Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages. Lancet 1907 2 : 160 2.
4. Bideau A, Plauchu H, Brunet G, Robert J. Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Population 1989 44 : 3 22.
5. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 1999 245 : 31 9.
6. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995 333 : 918 24.
7. Lesca G, Plauchu H, Coulet F, et al. Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France. Hum Mutat 2004 23 : 289 99.
8. Haitjema T, Westermann CJ, Overtoom TT, et al. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch Intern Med 1996 156 : 714 9.
9. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994 8 : 345 51.
10. Shovlin CL, Hughes JM, Scott J, Seidman CE, Seidman JG. Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 1997 61 : 68 79.
11. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996 13 : 189 95.
12. Berg JN, Gallione CJ, Stenzel TT, et al. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 1997 61 : 60 7.
13. Fernandez-L A, Sanz-Rodriguez F, Blanco FJ, Bernabeu C, Botella LM. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin Med Res 2006 4 : 66 78.
14. Toporsian M, Gros R, Kabir MG, et al. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 2005 96 : 685 96.
15. Sabbà C, Pasculli G, Lenato GM, et al. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 2007 5 : 1149 57.
16. Letteboer TGW, Zewald RA, Kamping EJ, et al. Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Duthch patients. Hum Genet 2005 116 : 8 16.
17. Gallione CJ, Richards JA, Letteboer TG, et al. SMAD4 mutations found in unselected HHT patients. J Med Genet 2006 43 : 793 7.
18. Cole SG, Begbie ME, Wallace GMF, Shovlin CL. A new locus for hereditary hemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 2005 42 : 577 82.
19. Bayrak-Toydemir P, McDonald J, Akarsu N, et al. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet 2006 140 : 2155 62.
20. Bossler AD, Richards J, George C, Godmilow L, Ganguly A. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype. Hum Mutat 2006 27 : 667 75.
21. Sabbà C, Gallitelli M, Pasculli G, Suppressa P, Resta F, Tafaro GE. HHT: a rare disease with a broad spectrum of clinical aspects. Curr Pharm Des 2006 12 : 1217 20.
22. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000 91 : 66 7.
23. Buscarini E, Plauchu H, Garcia-Tsao G, et al. Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int 2006 26 : 1040 6.
24. Kuehl HKA, Caselitz M, Hasenkamp S, et al. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations. Hum Mutat 2005 25 : 320.
25. Lesca G, Olivieri C, Burnichon N, et al. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med 2007 9 : 14 22.
26. Plauchu H, De Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an hepidemiologicaly recruited population. Am J Med Genet 1989 32 : 291 7.
27. Reilly PJ, Nostrant TT. Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 1984 79 : 363 7.
28. Buscarini E, Buscarini L, Danesino C, et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol 1997 26 : 111 8.
29. Buscarini E, Danesino C, Olivieri C, et al. Doppier ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia - results of estensive screening. Ultraschall Med 2004 25 : 348 55.
30. Stabile Ianora AA, Memeo M, Sabbà C, Cirulli A, Rotondo A, Angelelli G. Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement. Radiology 2004 230 : 250 9.
31. Ravard G, Soyer P, Boudiaf M, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: helical computed tomography features in 24 consecutive patients. J Comput Assist Tomogr 2004 28 : 488 95.
32. Ocran K, Rickes S, HeuKamp I, Wermke W. Sonographic findings in hepatic involvement of hereditary hemorrhagic telangiectasia. Ultraschall Med 2004 25 : 191 4.
33. Buonamico P, Suppressa P, Lenato GM, et al. Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: echo-color Doppler vs multislice computed tomography study. J Hepatol 2008 48 : 811 20.
34. Buscarini E, Danesino C, Olivieri C, Lupinacci G, Zambelli A. Liver involvement in hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber disease. Dig Liver Dis 2005 37 : 635 45.
35. Lerut J, Orlando G, Adam R, et al. European Liver Transplant Association. Liver transplantation for hereditary hemorrhagic telangiectasia: report of the European liver transplant registry. Ann Surg 2006 244 : 854 62.
36. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Patol Lab Med 1986 110 : 331 5.
37. Sawabe M, Arai T, Esaki Y, Tsuru M, Fukazawa T, Takubo K. Three-dimensional organization of the hepatic microvasculature in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 2001 125 : 1219 23.
38. Naganuma H, Ishida H, Niizawa M, Igarashi K, Shiya T, Masamune O. Hepatic involvement in Osler-Weber-Rendu disease: findings on pulsed and color Doppler sonography. AJR Am J Roentgenol 1995 165 : 1421 5.
39. Michaeli D, Ben-Bassat I, Miller HI, Deutsch V. Hepatic teleangiectases and porto-systemic encephalopathy in Osler-Weber-Rendu disease. Gastroenterology 1968 54 : 929 32.
40. Park JH, Cha SH, Han JK, Han MC. Intrahepatic portosystemic venous shunt. AJR Am J Roentgenol 1990 155 : 527 8.
41. Mori H, Hayashi K, Fukuda K, et al. Intrahepatic portosystemic venous shunt: occurrence in patients with and without liver cirrhosis. AJR Am J Roentgenol 1987 149 : 711 4.
42. Marteau P, Poupon R, Chazouilleres O, Darnis F. Rendu-Osler disease and focal nodular hyperplasia of the liver. Gastroenterol Clin Biol 1986 10 : 856.
43. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985 5 : 1194 200.
44. Buscarini E, Danesino C, Plauchu H, et al. High prevalence of focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol 2004 30 : 1089 97.
45. Bauer T, Britton P, Lomas D, Wight DG, Freiend PJ, Alexander GJ. Liver transplantation for hepatic arteriovenous malformation in hereditary hemorrhagic telangiectasia. J Hepatol 1995 22 : 586 90.
46. Blewitt RW, Brown CM, Wyatt JL. The pathology of acute disintegration in hereditary hemorrhagic telangiectasia. Histopathology 2003 42 : 265 9.
47. Garcia-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia. J Hepatol 2007 46 : 499 507.
48. Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000 343 : 931 6.
49. Livneh A, Langevitz P, Morag P, Catania A, Pras M. Functionally reversibile hepatic arteriovenous fistulae in hereditary hemorrhagic telangiectasia. Hepatogastroenterology 1988 81 : 1047 9.
50. Wu JS, Daluja S, Garcia-Tsao G, Chong A, Henderson KJ, White RI Jr. Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients. AJR Am J Roentgenol 2006 187 : 399 405.
51. Klepchik PR, Mc Lean GK. SIR 2006 film panel case: "Caroli's variant" hereditary hemorrhagic telangiectasia of the liver. J Vasc Interv Radiol 2006 17 : 1091 4.
52. Mc Inroy B, Zajko AB, Pinna AD. Biliary necrosis due to hepatic involvement with hereditary hemorrhagic telangiectasia. AJR Am J Roentgenol 1998 170 : 413 5.
53. Dominguez IB, Annet L, Waignein F, Sempoux C, Geubel A. Extensive ischemic liver necrosis complicating hereditary hemorrhagic telangiectasia: a rare indication for liver transplantation. Liver Int 2005 25 : 677 9.
54. Fagel WJ, Perlberger R, Kauffmann RH. Portosystemic encephalopathy in hereditary hemorrhagic telangiectasia. Am J Med 1988 85 : 858 60.
55. Rilling WS, Wible BC. SIR 2004 film panel case: hereditary hemorrhagic telangiectasia of the liver with mesenteric steal. J Vasc Interv Radiol 2004 15 : 1375 9.
56. Odorico JS, Hakim MN, Becjer YT, et al. Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. Liver Transplant Surg 1988 4 : 483 90.
57. Caselitz M, Bahr MJ, Bleck JS, et al. Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT). Hepatology 2003 37 : 1139 46.
58. Bernard G, Mion F, Henry L, Plauchu H, Paliard P. Hepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiological, and hemodynamic studies of 11 cases. Gastroenterology 1993 105 : 482 7.
59. Memeo M, Stabile Ianora AA, Scardapane A, Buonamico P, Sabbà C, Angelelli G. Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings. Abdom Imaging 2004 29 : 211 20.
60. Willinek WA, Hadizadeh D, von Falkenhausen M, et al. Magnetic resonance (MR) imaging and MR angiography for evaluation and follow-up of hepatic artery banding in patients with hepatic involvement of hereditary hemorrhagic telangiectasia. Abdom Imaging 2006 31 : 694 700.
61. Milot L, Gautier G, Beuf O, Pilleul F. Hereditary hemorrhagic teleangiectases: magnetic resonance imaging features in liver involvement. J Comput Assist Tomogr 2006 30 : 405 11.
62. Hashimoto M, Tate E, Nishii T, Watarai J, Shioya T, White RI. Angiography of hepatic vascular malformations associated with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 2003 26 : 177 80.
63. Matsumoto S, Mori H, Yamada Y, Hayashida T, Hori Y, Kiyosue H. Intrahepatic porto hepatic venous shunts in Rendu-Osler-Weber disease: imaging demonstration. Eur Radiol 2004 14 : 592 6.
64. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004 39 : 1 16.
65. Garcia-Tsao G, Sanyal AS, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007 46 : 922 38.
66. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000 407 : 249 57.
67. Sadick H, Naim R, Gossler U, Hormann K, Riedel F. Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density. Int J Mol Med 2005 15 : 15 9.
68. Flieger D, Hainke S, Fischbach W. Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab. Ann Hematol 2006 85 : 631 2.
69. Mitchell A, Adams LA, Mac Quillan G, Tibbals J, vanden Driesen R, Delriviere L. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl 2008 14 : 210 3.
70. Chavan A, Caselitz M, Gratz KF, et al. Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations. Eur Radiol 2004 14 : 2079 85.
71. Ludwig J, Kim CH, Wiesner RH, Krom RA. Floxuridine-induced sclerosing cholangitis: an ischemic colangiopathy? Hepatology 1989 9 : 215 8.
72. Kamath PS, Kim WR. Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology 2007 45 : 797 805.
73. Sabbà C, Gallitelli M, Longo A, Cariati M, Angelelli G. Orthotopic liver transplantation and hereditary hemorrhagic telangiectasia: do hepatic malformations relapse? A long term follow up study on two patients. J Hepatol 2004 41 : 687 9.